CRA Buys Psychiatric Trial Firm CCD
Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.
Archives for July 24, 2013
Drug Pack Leak Test Firm Sepha Bought By Tasi
Tasi Group has acquired pharmaceutical leak testing firm Sepha and plans to seek more customers overseas.
Aesica Adds Stealthy Anti-Abuse Tech to Controlled Drug Offering
Aesica has licensed an anti-abuse technology from QRxPharma that it claims outperforms all other solutions currently on the market.
update
Lonza and Teva Abandon Biosimilars JV; Lonza Plans Site 'Consolidations'
Lonza says developing biosimilars with Teva would have been too costly and any biologics produced would have taken too long to bring to market.
Consistent Trial Site Payments Key to Long-Term Relationships with Investigators
The days of using Excel spreadsheets to manage clinical trial site payments are now in the past, especially as CROs and sponsors look to retain their most highly-prized sites and establish long-term relationships for future trials.
People: Chiltern to Expand its Global Pharmacovigilance
Chiltern has a new Director of Global Pharmacovigilance and there's an appointment at DSM in this week's lowdown on the outsourcing industry's movers and shakers.
Mystery Pill Causes Prompt Paracetamol Recall in Australia
Australian firm Ascent Pharmaceuticals has issued a recall of one batch of paracetamol after concerns bottles may contain a foreign tablet.